A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis
- PMID: 11728344
- DOI: 10.1016/s1074-7613(01)00232-1
A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis
Abstract
TWEAK is a member of the TNF ligand family that induces angiogenesis in vivo. We report cloning of a receptor for TWEAK (TweakR) from a human umbilical vein endothelial cell (HUVEC) library. The mature form of TweakR has only one hundred and two amino acids and six cysteine residues in its extracellular region. Five different assays demonstrate TWEAK-TweakR binding, and the interaction affinity constant (Kd) is within a physiologically relevant range of 2.3 +/- 0.1 nM. The TweakR cytoplasmic domain binds TRAFs 1, 2, and 3. Cross-linking of TweakR induces HUVEC growth, and mRNA levels are upregulated in vitro by a variety of agents and in vivo following arterial injury. Soluble TweakR inhibits endothelial cell migration in vitro and corneal angiogenesis in vivo.
Similar articles
-
TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):241-9. doi: 10.1016/s1359-6101(03)00019-4. Cytokine Growth Factor Rev. 2003. PMID: 12787562 Review.
-
Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells.Biochem Biophys Res Commun. 2002 Dec 6;299(3):488-93. doi: 10.1016/s0006-291x(02)02670-0. Biochem Biophys Res Commun. 2002. PMID: 12445828
-
A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.J Immunol. 2007 Jun 15;178(12):8183-94. doi: 10.4049/jimmunol.178.12.8183. J Immunol. 2007. PMID: 17548657
-
TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.J Biol Chem. 2003 Aug 22;278(34):32317-23. doi: 10.1074/jbc.M302518200. Epub 2003 Jun 6. J Biol Chem. 2003. PMID: 12794080
-
The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.Front Biosci. 2004 Sep 1;9:2273-84. doi: 10.2741/1395. Front Biosci. 2004. PMID: 15353286 Review.
Cited by
-
TWEAK promotes exercise intolerance by decreasing skeletal muscle oxidative phosphorylation capacity.Skelet Muscle. 2013 Jul 8;3(1):18. doi: 10.1186/2044-5040-3-18. Skelet Muscle. 2013. PMID: 23835416 Free PMC article.
-
Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer.Exp Ther Med. 2011 Jan;2(1):103-108. doi: 10.3892/etm.2010.181. Epub 2010 Dec 2. Exp Ther Med. 2011. PMID: 22977477 Free PMC article.
-
TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.Arthritis Res Ther. 2006;8(5):R146. doi: 10.1186/ar2038. Arthritis Res Ther. 2006. PMID: 16945157 Free PMC article.
-
The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation.Biochem J. 2003 Apr 15;371(Pt 2):395-403. doi: 10.1042/BJ20021730. Biochem J. 2003. PMID: 12529173 Free PMC article.
-
TWEAKing death.J Cell Biol. 2008 Jul 14;182(1):15-7. doi: 10.1083/jcb.200806036. Epub 2008 Jul 7. J Cell Biol. 2008. PMID: 18606854 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases